Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED BALANCE SHEETS

v3.19.3
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Sep. 30, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 6,215 $ 5,342
Premium and trade receivables 5,606 5,150
Short-term investments 804 722
Other current assets 832 784
Total current assets 13,457 11,998
Long-term investments 7,915 6,861
Restricted deposits 655 555
Property, software and equipment, net 1,993 1,706
Goodwill 6,872 7,015
Intangible assets, net 2,086 2,239
Other long-term assets 1,274 527
Total assets 34,252 30,901
Current liabilities:    
Medical claims liability 7,975 6,831
Accounts payable and accrued expenses 4,010 4,051
Return of premium payable 848 666
Unearned revenue 381 385
Current portion of long-term debt 66 38
Total current liabilities 13,280 11,971
Long-term debt 6,975 6,648
Other long-term liabilities 1,561 1,259
Total liabilities 21,816 19,878
Commitments and contingencies
Redeemable noncontrolling interests 31 10
Stockholders’ equity:    
Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at September 30, 2019 and December 31, 2018 0 0
Common stock, $0.001 par value; authorized 800,000 shares; 419,667 issued and 413,793 outstanding at September 30, 2019, and 417,695 issued and 412,478 outstanding at December 31, 2018 0 0
Additional paid-in capital 7,571 7,449
Accumulated other comprehensive earnings (loss) 145 (56)
Retained earnings 4,775 3,663
Treasury stock, at cost (5,874 and 5,217 shares, respectively) (180) (139)
Total Centene stockholders’ equity 12,311 10,917
Nonredeemable Noncontrolling interest 94 96
Total stockholders’ equity 12,405 11,013
Total liabilities, redeemable noncontrolling interests and stockholders’ equity $ 34,252 $ 30,901